Adalimumab in active ulcerative colitis: A “real-life” observational study-Reference-Cited by-同舟云学术

Adalimumab in active ulcerative colitis: A “real-life” observational study

Published:2013-09 Issue:9 Volume:45 Page:738-743
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Armuzzi Alessandro,Biancone Livia,Daperno Marco,Coli Alessandra,Pugliese Daniela,Annese Vito,Aratari Annalisa,Ardizzone Sandro,Balestrieri Paola,Bossa Fabrizio,Cappello Maria,Castiglione Fabiana,Cicala Michele,Danese Silvio,D’Incà Renata,Dulbecco Pietro,Feliciangeli Giuseppe,Fries Walter,Genise Stefania,Gionchetti Paolo,Gozzi Stefano,Kohn Anna,Lorenzetti Roberto,Milla Monica,Onali Sara,Orlando Ambrogio,Papparella Luigi Giovanni,Renna Sara,Ricci Chiara,Rizzello Fernando,Sostegni Raffaello,Guidi Luisa,Papi Claudio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. The course and prognosis of ulcerative colitis;Edwards;Gut,1963

2. Therapeutic strategies for the management of ulcerative colitis;Ng;Inflammatory Bowel Diseases,2009

3. Ulcerative colitis;Danese;New England Journal of Medicine,2011

4. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;New England Journal of Medicine,2005

5. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Järnerot;Gastroenterology,2005

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort;Crohn's & Colitis 360;2024-07-01

3. Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis;Pharmacological Research;2024-04

4. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry;Therapeutic Advances in Gastroenterology;2024-01

5. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy;World Journal of Gastroenterology;2022-09-14